Drug Type Monoclonal antibody |
Synonyms- |
Target |
Action inhibitors |
Mechanism MAGEA4 inhibitors(Melanoma-associated antigen 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Synovial Sarcoma | Preclinical | United States | 27 Apr 2025 | |
Synovial Sarcoma | Preclinical | United States | 27 Apr 2025 |